Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × cabozantinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 25 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Prostatic Neoplasms 3 Osteosarcoma 3 Melanoma 3 Kidney Neoplasms 3 Colorectal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Penile Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Brain Neoplasms 2 Adrenocortical Carcinoma 2 von Hippel-Lindau Disease 1 Urologic Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Seminoma 1 Sarcoma, Kaposi 1

Interventions

pembrolizumab 18 Radiotherapy 10 Cisplatin 10 Carboplatin 9 Cetuximab 8 Paclitaxel 7 Drug Therapy 4 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Docetaxel 3 toripalimab 2 tislelizumab 2 palbociclib 2 osimertinib 2 fludarabine 2 X-Rays 2 Surveys and Questionnaires 2 Standard of Care 2 Radiation 2 Pravastatin 2 Magnetic Resonance Spectroscopy 2 Ketoprofen 2 Fulvestrant 2 Fluorouracil 2 Equipment and Supplies 2 Cyclophosphamide 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Afatinib 2 ulixertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡